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Single cell metabolomics
Matthias Heinemann1,2 and Renato Zenobi3Recent discoveries suggest that cells of a clonal population
often display multiple metabolic phenotypes at the same time.
Motivated by the success of mass spectrometry (MS) in the
investigation of population-level metabolomics, the analytical
community has initiated efforts towards MS-based single cell
metabolomics to investigate metabolic phenomena that are
buried under the population average. Here, we review the
current approaches and illustrate their advantages and
disadvantages. Because of significant advances in the field,
different technologies are now at the verge of generating data
that are useful for exploring and investigating metabolic
heterogeneity.
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Introduction
Quantitative metabolomics, the technology for large-scale
quantification of intracellular metabolite concentrations, is
a powerful tool in systems biology research that has
recently led to a series of interesting findings (e.g.
[1–4]). Because of the metabolome’s chemical diversity,
mass spectrometry (MS) is the analytical method of choice
[5]. In addition to analytical challenges, quantitative meta-
bolomics as required for addressing (systems) biology
questions poses significant challenges in sample proces-
sing. One important challenge is the need to preserve the
original metabolome during sample processing, which is
often difficult because of the presence of enzymes in the
sample and the fast metabolic turnover rates.
For sensitivity reasons, current metabolomics methods
require samples that contain a large number of cells.
However, cell populations are not necessarily homo-Current Opinion in Biotechnology 2011, 22:26–31geneous. Besides genetic differences, several other
sources for population heterogeneity exist, of which sev-
eral are also known to cause metabolic differences.
Today, methods capable of resolving differences in
metabolite levels on the single cell level are provided,
within limits, by molecular sensors such as FRET sensors
[6,7] or aptamer-based technology [8,9]. Both types of
molecular sensors, however, are difficult to develop, are
limited to specific analytes, and quantitative analyses (e.g.
in terms of mol/L) are hardly possible with them. Laser-
induced fluorescence, as introduced by Dovichi for single
cell proteomics, is limited to fluorescent compounds or
labelled species [10,11]. In addition, all these existing
methods share the limitation that they can never be
extended to the ‘‘-omics’’ level, that is to measuring a
large number of metabolites at the same time. They will
thus not be applicable to discovery type research and
research that requires a large number of metabolites to be
measured in the same cell.
Because of the success of mass spectrometry in popu-
lation-level metabolome analyses, the analytical com-
munity has recently made great strides towards single
cell level metabolite analyses (for a review, see [12]). So
far, however, hardly any new biological insight has been
generated from these endeavours. In this Current Opinion
paper, we will thus not only review the current status of
MS-based single cell metabolomics but also discuss which
of the different approaches will have the best chance to be
useful for addressing (systems) biological questions. We
intend to update the interested biology community on
how far single cell metabolomics has been developed by
analytical chemists, and help the analytical community to
guide their efforts towards the needs of the future users in
(systems) biology.
Why single cell metabolomics?
The metabolome is arguably the most sensitive measure
of a cellular phenotype [13]. Thus, metabolomics is not
only an essential experimental tool for metabolism-
related research: we anticipate that it will also become
a powerful tool for general screening studies, because of
its potential to uncover phenotypic differences in a very
sensitive manner. The power of metabolomics can be
exploited in population-level measurements, but as cell
populations are not necessarily homogeneous, it will be
even more informative to measure at the single cell level.
There are multiple reasons for cellular heterogeneity:
cells can be genetically different, can experience a differ-
ent microenvironment, might have had a different
history, are in different developmental or cell-cyclewww.sciencedirect.com
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metabolism at the single cell level are still largely lacking,
the research community has almost no knowledge about
the metabolic phenotypes of individual cells in hetero-
geneous populations. However, from a limited number of
experiments with sorted cell populations and from some
other reasoning, it is clear that significant differences in
the metabolome are to be expected. For example, from
population-level metabolomic measurements on cell-
cycle-synchronized yeast cells, it was found that signifi-
cant changes in gene regulation and metabolite levels
occur during the cell cycle [14]. Also, the age of a yeast
cell was argued to influence the metabolic phenotype in
clonal cells: In cells that were sorted according to their
age, dramatic metabolic differences were found [15–17].
Synchronizing as well as sorting cells likely affects the
metabolome, due to fast metabolic turnover rates.
Typical sorting methods do not account for any metabolic
changes that occur during the process, such that the
available measurements might not reflect the original
metabolome. Thus, even such studies, where information
on the metabolic phenotypes of certain subpopulations
already exists, would also tremendously benefit from
single cell metabolomics technology.
In addition to the abovementioned sources for hetero-
geneity, stochasticity-induced phenotypic heterogeneity
was identified a few years ago as an additional source of
cell-to-cell variability [18,19]. Because of low copy num-
bers of specific biomolecules, certain processes at the
gene and protein expression level are inherently stochas-
tic and can cause random fluctuations in the abundance of
biomolecules. These fluctuations can be exploited by a
number of regulatory feedback mechanisms to create
multiple distinct and coexisting phenotypes even from
isogenic cells in the same environment and in cells with
the same history (cf. reviews cited above). The two
prerequisites for stochasticity-induced phenotypic
heterogeneity [20,21] are met in practically every biomo-
lecular network. Thus it is very likely that the currently
known cases of such heterogeneity merely represent the
tip of the iceberg of all of these cases [22].
In fact, this type of heterogeneity was also found to occur
in metabolic systems: the well-known lactose utilization
system in Escherichia coli was found to display an ‘‘all or
none’’ type of behaviour, where single cells stochastically
transit between the two states [23]. Another example is
the galacatose ultilization network in yeast displaying
bimodal patterns in the expression of the GAL family
genes responsible for galactose metabolism [24]. A recent
report about the presence of several global feedback loops
overarching metabolic and transcriptional regulation inE.
coli [25] indicates that in fact many more metabolically
different stable phenotypes could be uncovered — if we
were only able to experimentally probe metabolism of
individual cells. Metabolically different phenotypes maywww.sciencedirect.comunderlie the medically highly relevant microbial pheno-
types of persister cells [26], dormant cells [27] or small
colony variants [28].
Overall, a technology to measure metabolite levels in
single cells would be an excellent tool for firstly discovery
of metabolic differences in individual cells (for which
likely semi-quantitative methods will be sufficient) and
secondly system biology endeavours that aim at generat-
ing an understanding about the emergence of such phe-
notypic or genetic heterogeneity (for which likely more
quantitative methods will be required).
Challenges for single cell metabolomics
Single cell metabolomics poses enormous challenges:
First, it has to deal with minute quantities of analytes.
In E. coli, a bacterium with about 1 fL of volume [29],
even highly abundant glycolytic intermediates, which are
present in the low mM concentration range, require
detection sensitivity in the low attomole range. In the
budding yeast, with a volume of about 65 fL [29],
amounts in the two- to three-digit attomole range must
be detected. In mammalian cells, with a 500 fL volume
[29], metabolites would be expected in the two-digit
femtomole range (assuming similar metabolite concen-
tration levels as in microbes). Compared to themetabolite
amounts that are typically used for classical population-
level metabolomics (nanomoles), single cell metabolo-
mics for E. coli has to handle amounts that are approxi-
mately 109 times lower. Unlike in single cell genomics
and proteomics, amplification of analyte and/or highly
sensitive fluorescence measurements on labelled com-
pounds cannot be used for single cell metabolomics.
Recently, the limits of detection for metabolites using
mass spectrometry have been lowered from typically
femtomoles to the low attomole range which is the range
that is required for single cell metabolomics [30]. How-
ever, even if such small quantities can be detected,
quantification is still problematic, and so is handling of
the minute sample quantities (originating from an indi-
vidual cell). Transfer of a cell (content) to the mass
spectrometer, ideally without any losses, harbours signifi-
cant challenges, especially because the sample processing
needs to conserve the original metabolome (which can,
for example, be distorted if enzymatic activity is still
present in the sample). Furthermore, quantitative ma-
ss-spectrometric analyses typically require the metab-
olites to be separated from cell debris, proteins, and
salts, to reduce ion suppression.
In order for a single cell metabolomics technology to be
useful for (systems) biology research, it is important that
the technology can either measure a wide range of
metabolites such that the technology could be used for
phenotypic screening on the single cell level or can
measure and quantify fewer metabolites in a targetedCurrent Opinion in Biotechnology 2011, 22:26–31
28 Analytical biotechnologymanner. Further, the technology should reproducibly
provide at least semi-quantitative data. For this, it is
important that not only the actual analysis step is quan-
titative, but also the sample processing is done in an
appropriate way. Finally, because single cell metabolo-
mics technology is expected to reveal differences be-
tween few individual cells, the technology also needs
to generate sufficient measurement throughput to allow
meaningful statistical analyses of the data will.
MS-based approaches for single cell
metabolomics
On the population level, mass spectrometry has become
the key enabling technologies formetabolomics, providing
high-resolution data. In recent years, an increasing number
of papers have been published on the topic of MS-based
single cell metabolomics. Almost exclusively, papers on
this topic have appeared in analytical journals and have
focused on the technology development; real biological
insight hasnot yet beengenerated. In the following,wewill
illustrate the different approaches pursued (Figure 1) and
will discuss to what extent these technologies have the
potential to generate data relevant for (systems) biology.
(a) Sampling the cell contents with a micropipette, followed by
injection into a mass spectrometer using a nano-electro-
spray ionization (nano-ESI) source. This approach,
which is probably only suitable for very large cells, has
been pursued by Masujima [31] who also coined the
term ‘‘live single cell video-mass spectrometry’’ for it,
to indicate that the cytoplasm, or in some cases even
subcellular material, is sampled under a video
microscope with a small pipette that can then be
directly used for generating ions via nano-ESI.
Although the same group has presented some
(unpublished) work on robotic handling of the
pipetting process, this approach is hardly amenable
to high-throughput operation: only a few cells can
be measured per hour. Unless the throughput can beFigure 1
Schematics of the four MS-based approaches for single cell metabolomics.
Current Opinion in Biotechnology 2011, 22:26–31dramatically improved, this approach will thus not
really be relevant for systems biology, because it will
be likely impossible to generate statically sound data
on cellular heterogeneity. On the other hand, this is
the method that has so far yielded by far the greatest
variety of signals, with more than a dozen signals that
were clearly distinct from the abundant background
signals. For example, metabolites such as histamine,
serotonin, and leukotriene B4 could be detected in
individual mast cells. Identification by tandem mass
spectrometry was done off-line, on samples stemming
from a large number of cells. In addition to
metabolites, enzymes are also sucked into the needle,
such that distortion of the original metabolome can be
an issue.
(b) Sample preparation on a microfluidic chip, followed by
deposition on a sample plate for (matrix-assisted) laser
desorption/ionization (MALDI or LDI) mass spectrom-
etry. For this approach, single cell organisms are first
processed on a microfluidic chip with steps for
quenching, lysis, and separation of metabolites from
the rest of the cell content. The cell content is then
transferred to a mass spectrometer with a suitable
interface. Conceptually, this approach represents a
downscaling of the classical metabolomics approach.
The complete setup has not yet been realized, but
many different units required for the microfluidic
chip have been developed separately, such as lysis
(see, for example, [32]), impedance-based cell size
measurement [33], CE separation (e.g. [34]). Also, it
has already been demonstrated for metabolites
including UDP, ADP, GDP, UTP, ATP, GTP,
acetyl-CoA, and butyryl/isobutyryl-CoA that the
sensitivity for MALDI-based MS detection of
metabolites will be sufficient to reach the single
yeast cell level [30] and a suitable technology for
sample deposition (‘‘writing’’ onto a MALDI plate)
was also proposed [12,35,36] allowing for convenient
off-line mass-spectrometric analysis. Coupling of thewww.sciencedirect.com
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possible, which, however, requires on-line MS
analysis. Once the overall operation of this technol-
ogy has been demonstrated, it is likely that this
technology has the potential to generate high-
throughput data in an automated way.
(c) Sample arraying. In this approach, suitable for single
cell organisms, a sample plate for LDI or MALDI is
covered by a solvent-repelling (‘‘omniphobic’’) coat-
ing that has been patterned to form a dense
checkerboard arrangement of hydrophilic recipient
sites approximately 50–200 mm in size, matched to
the size of the laser focus. These spots are ‘‘anchors’’
for small volumes of liquid that will automatically
form a checkerboard pattern of quite monodisperse
sample droplets after spreading a cell suspension onto
this patterned plate. If an appropriate concentration
of cells is used, spreading of the sample will result in
the deposition of 1 cell (in rare cases, two cells) per
recipient site. An advantage of this approach is that
the size of the cells to be analyzed may be distinctly
smaller than the recipient site. The plate can be
cooled to stop the metabolism instantaneously upon
applying the cell suspension. Application of a
MALDI matrix in an organic solvent will then lyse
the cells and extract the compounds of interest for
analysis by MALDI. So far, high-abundance metab-
olites (e.g. ADP, GDP, UTP, ATP, GTP and GDP-
Glc) have been detected by negative ion mode
MALDI-MS in small algae and in single yeast cells.
We have hints that this sample presentation mode
also facilitates quantitation, because the signals from
recipient sites containing two cells are about twice as
high as from those with only one cell. This approach
provides true high-throughput operation: the sample
deposition is an automated, parallel process, and the
readout of the spectra is fast, limited only by the
speed of the MS instrument (2 spots per second,
that is analysis of 1000s of cells/hour) [39].
(d) Imaging mass spectrometry. Many modern mass spec-
trometers have imaging capabilities, with a spatial
resolution of typically50 mm (MALDI or LDI), and
1 mm (secondary ion mass spectrometry, SIMS), as
well as relatively fast acquisition speed [40,41].
Unless the cells are much smaller than 50 mm,
MALDI-MS imaging thus has the capability to
yield single cell analyses of compounds including
metabolites. Imaging MS is most often applied to
analyzing tissues. Interesting work in this area has
been published by various groups. Sweedler and
coworkers have pioneered the quantitative analysis of
neurotransmitters and neuropeptides in single
neurons of rats and the sea snail Aplysia californica
[42]; the latter, however, are really gigantic. Inter-
esting sample preparation protocols have been
developed by the same group [43]. Another recent
example is MS imaging of the distribution ofwww.sciencedirect.comsecondary flavonoid metabolites such as kaempferol,
quercetin, isorhamnetin, and their glycosides in
individual plant tissue cells [44]. A spatial resolution
of 10 mm was reached with state-of-the-art LDI
instrumentation. SIMS imaging of cells is capable of
even higher spatial resolution, but has not really been
extended to detecting metabolites. With this tech-
nology the distribution of ions such as Na+, K+, Ca2+,
as well as cationized cholesterol, lipids, or their
fragments, that is molecules present at cell surfaces
has usually been imaged [41]. It remains to be shown
that SIMS imaging will also be able to detect
intracellular metabolites. SIMS is notorious for
suffering from ionization matrix effects, and such it
seems unlikely that it will yield quantitative data.
Conclusion
The importance of metabolism for health and disease is
currently being rediscovered, and combined with the
recent discovery of stochasticity-induced phenotypic
bistability as one source of population heterogeneity, it
is clear that technologies for metabolomics on the single
cell level will be required.
The analytical field has started to develop technologies
for MS-based single cell metabolomics, as seen from the
increasing number of publications in this area. However,
so far, all efforts in single cell metabolomics seem to
remain only within the analytical community. The chal-
lenge for the near future will be to bring together the
efforts of the analytical community with current interests
in the area of (systems) biology, such that the techno-
logical efforts can be guided towards the needs of future
users in biology. Here, the analytical community will
likely face requests for proper sample handling pro-
cedures (i.e. procedures that conserve the original meta-
bolome) and for targeted measurement of certain specific
metabolites. In current single cell metabolomics papers
often rather exotic classes of metabolites were reported—
presumably simply because these were the only metab-
olites that were easily detected. For application of single-
cell metabolomics technology to biological research, how-
ever, it likely will be necessary to specify metabolites (or
metabolite classes) to be measured.
We feel that ultimately the approach to couple a micro-
fluidic unit to a mass spectrometer has the highest poten-
tial to deliver relevant data for systems biology. Here, the
major challenges will be — apart from solving the quanti-
fication issue — to integrate all the single steps into a
whole system. We hope that within the next two or three
years such systems will become available.
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